🔴 High ImpactPharma
Aurobindo Pharma USA gets FTC nod to buy Lannett
Aurobindo Pharma USA gets FTC nod to buy Lannett.
The acquisition of Lannett Company has received approval from the U.S. Federal Trade Commission, clearing a key regulatory hurdle. This deal significantly expands Aurobindo’s presence in the U.S. generics market. The transaction is expected to close soon, pending final conditions.
📊 STOCKS: AUROPHARMA | 🏢 SECTOR: Pharma | #HIGHIMPACT #Mergers
#Mergers#Regulatory#USMarket
Stocks mentioned
⚠️ This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.
Trade smarter on NSE
Live option chains, FII flows, PCR, AI analysis — for NIFTY, BANKNIFTY & 200+ F&O stocks.
Start for ₹1 →